🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Corticosteroid Versus PRP Injections for Shoulder Tendinopathy

RecruitingNAAges 18 Years - anyAllHopital Charles Nicolle
NCT07094178 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Shoulder tendinopathy is a common condition that causes shoulder pain and limits daily activities. It often results from damage or overuse of the rotator cuff tendons. Treatment typically includes rest, physical therapy, anti-inflammatory medications, and sometimes injections. This clinical trial aims to compare the effectiveness of two types of injections for treating simple shoulder tendinopathy: Corticosteroid injections, which reduce inflammation and provide quick pain relief, but may have only short-term effects. Platelet-Rich Plasma (PRP) injections, a newer treatment made from the patient's own blood, which may promote long-term healing. The study is being conducted at the Rheumatology Department of Charles Nicolle Hospital in Tunis, Tunisia. A total of 60 adult patients with shoulder tendinopathy will be randomly assigned to receive either a corticosteroid injection or a PRP

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Adults aged 18 years and older * Diagnosed with simple tendinopathy of the shoulder confirmed by clinical examination and imaging * Experiencing shoulder pain for at least 4 weeks * Able to provide informed consent Exclusion Criteria: * Previous shoulder surgery on the affected side * Presence of rotator cuff tear or severe shoulder pathology * Systemic inflammatory diseases (e.g., rheumatoid arthritis) * Recent corticosteroid injection in the affected shoulder (within last 3 months) * Contraindications to corticosteroids or PRP treatment * Pregnancy or breastfeeding
💊

What it tests

  • Corticosteroid Injection
  • platelet-rich plasma injection
📍

Where

1 site
Charles Nicolle Hospital
Tunis, Tunisia
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy